Modelling cost-benefit of NGS for personalized tuberculosis control in German healthcare services

Bibliografische Angaben

Nachweis in CareLit

Kernaussage aus der Literatur

Abstract-Vorschau

New genomic technologies such as next-generation sequencing (NGS) may yield information on multiple genetic developments of Mycobacterium tuberculosis (MTB). Basically, NGS allows management of contact investigation to be targeted especially at contacts likely to benefit, thus reducing secondary TB morbidity and follow-up treatment costs in the near future. However, NGS has not been implemented widely, despite of it…

Zitieren

Zitierempfehlung

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur